Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Malignant adenomyoepithelioma of the breast: seven cases illustrating morphological diversity and diagnostic challenges.

Histopathology·2026
Same author

Modeling Zn<sub>3</sub>O<sub>3</sub>/Ga<sub>3</sub>O<sub>3</sub> composite for water splitting: a first-principle DFT study of electronic structure and interfacial reactivity.

Scientific reports·2026
Same author

Oncostatin level and Tumour necrosis factor-alpha gene polymorphism in predicting Blastocystis infection in inflammatory bowel disease.

Acta tropica·2026
Same author

Triple-negative breast cancer: a threshold-defined diagnostic category within a biological continuum.

Journal of clinical pathology·2026
Same author

Breast core needle biopsy diagnosis and personalized treatment: navigating pitfalls and challenging lesions.

Histopathology·2026
Same author

Contextual interpretation of luminal phenotype in low-grade breast epithelial proliferations.

Journal of clinical pathology·2026
Same journal

Correction: Adeluola et al. Chemoprevention of 4-NQO-Induced Oral Cancer by the Combination of Resveratrol and EGCG: In Vivo, In Silico and In Vitro Studies. <i>Cancers</i> 2026, <i>18</i>, 1098.

Cancers·2026
Same journal

Correction: Peñalver et al. Guidelines for Diagnosis, Treatment, and Follow-Up of Patients with Follicular Lymphoma-Spanish Lymphoma Group (GELTAMO) 2026. <i>Cancers</i> 2026, <i>18</i>, 395.

Cancers·2026
Same journal

Correction: Accorsi Buttini et al. Development of a Simplified Geriatric Score-4 (SGS-4) to Predict Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Patients Aged over 50. <i>Cancers</i> 2025, <i>17</i>, 3278.

Cancers·2026
Same journal

Age-Stratified Long-Term Outcomes of Immune Checkpoint Inhibitors for Stage IV Melanoma and NSCLC in The Netherlands: A Population-Based Study.

Cancers·2026
Same journal

Targeting Ferroptosis in Glioblastoma: Molecular Mechanisms, Tumor Microenvironment, and Therapeutic Opportunities.

Cancers·2026
Same journal

Neoadjuvant Immunotherapy-Based Treatment Versus Chemotherapy Alone in Resectable Locally Advanced dMMR/MSI-H Gastric Cancer: A Real-World Study with Meta-Analysis.

Cancers·2026
See all related articles

Related Experiment Video

Updated: Jun 6, 2025

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
07:54

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

18.6K

Characterization of Breast Cancer Intra-Tumor Heterogeneity Using Artificial Intelligence.

Ayat G Lashen1,2, Noorul Wahab3, Michael Toss1

  • 1Breast Cancer Research Unit, University of Nottingham, Nottingham NG7 2RD, UK.

Cancers
|November 27, 2024
PubMed
Summary
This summary is machine-generated.

Intra-tumor heterogeneity (ITH) in breast cancer (BC) is complex. Deep learning models accurately assessed ITH, revealing it predicts aggressive tumor behavior and poor patient outcomes in early-stage luminal BC.

Keywords:
artificial intelligencebreast cancerintra-tumor heterogeneity

More Related Videos

Quantification of Breast Cancer Cell Invasiveness Using a Three-dimensional 3D Model
08:08

Quantification of Breast Cancer Cell Invasiveness Using a Three-dimensional 3D Model

Published on: June 11, 2014

15.8K
Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
11:34

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on: December 5, 2017

12.6K

Related Experiment Videos

Last Updated: Jun 6, 2025

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
07:54

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

18.6K
Quantification of Breast Cancer Cell Invasiveness Using a Three-dimensional 3D Model
08:08

Quantification of Breast Cancer Cell Invasiveness Using a Three-dimensional 3D Model

Published on: June 11, 2014

15.8K
Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
11:34

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on: December 5, 2017

12.6K

Area of Science:

  • Oncology
  • Computational Pathology
  • Medical Imaging

Background:

  • Intra-tumor heterogeneity (ITH) is a key feature of breast cancer (BC), impacting disease progression, prognosis, and treatment efficacy.
  • Accurate characterization of ITH in BC remains a significant challenge due to its inherent complexity.

Purpose of the Study:

  • To utilize deep learning (DL) techniques for comprehensive evaluation of ITH in early-stage luminal breast cancer.
  • To elucidate the impact of ITH on tumor behavior and patient outcomes using advanced computational methods.

Main Methods:

  • A large cohort of 2561 early-stage luminal BC cases was analyzed using whole slide images (WSIs).
  • Morphological features from tumor and stromal components were annotated, and a DL model was developed to quantify heterogeneity.
  • An overall heterogeneity score was generated and correlated with clinicopathological features and patient outcomes.

Main Results:

  • 162 morphological features were quantified, showing significant inter-feature correlations.
  • High ITH was significantly associated with larger tumor size, poor differentiation, high proliferation, no special type (NST) tumors, and low estrogen receptor (ER) expression.
  • A high overall heterogeneity score independently predicted poor patient outcomes and was linked to aggressive tumor behavior.

Conclusions:

  • Deep learning models offer a powerful approach to accurately decipher the complexity of intra-tumor heterogeneity in breast cancer.
  • DL-derived heterogeneity metrics provide valuable supplementary information for predicting patient outcomes in early-stage luminal BC.